Molecular relapse monitoring reveals the domination of impaired NK cell education over impaired inhibition in missing KIR-ligand recognition in patients after unrelated hematopoietic stem cell transplantation for malignant diseases.

Nowak J, Witkowska A, Rogatko-Koroś M, Malinowska A, Graczyk-Pol E, Nestorowicz-Kałużna K, Flaga A, Szlendak U, Wnorowska A, Gawron A

Open source

DOI
10.1111/tan.15364
Published
2024 Feb
Container
HLA
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/tan.15364,
  title = {Molecular relapse monitoring reveals the domination of impaired NK cell education over impaired inhibition in missing KIR-ligand recognition in patients after unrelated hematopoietic stem cell transplantation for malignant diseases.},
  author = {Nowak J and Witkowska A and Rogatko-Koroś M and Malinowska A and Graczyk-Pol E and Nestorowicz-Kałużna K and Flaga A and Szlendak U and Wnorowska A and Gawron A},
  year = {2024},
  journal = {HLA},
  doi = {10.1111/tan.15364},
  url = {https://doi.org/10.1111/tan.15364}
}

RIS

TY  - JOUR
TI  - Molecular relapse monitoring reveals the domination of impaired NK cell education over impaired inhibition in missing KIR-ligand recognition in patients after unrelated hematopoietic stem cell transplantation for malignant diseases.
AU  - Nowak J
AU  - Witkowska A
AU  - Rogatko-Koroś M
AU  - Malinowska A
AU  - Graczyk-Pol E
AU  - Nestorowicz-Kałużna K
AU  - Flaga A
AU  - Szlendak U
AU  - Wnorowska A
AU  - Gawron A
PY  - 2024
JO  - HLA
DO  - 10.1111/tan.15364
UR  - https://doi.org/10.1111/tan.15364
ER  - 

APA

J, N., A, W., M, R., A, M., E, G., K, N., A, F., U, S., A, W., & A, G. (2024). Molecular relapse monitoring reveals the domination of impaired NK cell education over impaired inhibition in missing KIR-ligand recognition in patients after unrelated hematopoietic stem cell transplantation for malignant diseases.. HLA. https://doi.org/10.1111/tan.15364

Source records